Farther Finance Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
634
+6
| +1% | +$1.55K | ﹤0.01% | 1485 |
|
|
2025
Q1 | $140K | Sell |
628
-31
| -5% | -$6.89K | ﹤0.01% | 1382 |
|
|
2024
Q4 | $151K | Sell |
659
-9
| -1% | -$2.06K | 0.01% | 1125 |
|
|
2024
Q3 | $163K | Buy |
668
+28
| +4% | +$6.84K | 0.01% | 1082 |
|
|
2024
Q2 | $120K | Sell |
640
-242
| -27% | -$45.2K | 0.01% | 1055 |
|
|
2024
Q1 | $167K | Buy |
882
+148
| +20% | +$28K | 0.01% | 750 |
|
|
2023
Q4 | $126K | Buy |
734
+544
| +286% | +$93.5K | 0.01% | 716 |
|
|
2023
Q3 | $28.1K | Buy |
190
+42
| +28% | +$6.21K | ﹤0.01% | 987 |
|
|
2023
Q2 | $32.3K | Buy |
148
+4
| +3% | +$874 | 0.01% | 827 |
|
|
2023
Q1 | $31.5K | Buy |
144
+18
| +14% | +$3.94K | 0.01% | 755 |
|
|
2022
Q4 | $26.2K | Buy |
+126
| New | +$26.2K | 0.01% | 647 |
|